FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology, specifically to the production of vaccine constructs against staphylococcus intramammary infection (hereinafter – IMI).
EFFECT: obtained constructs containing an amino acid sequence SEQ ID NO: 3 or SEQ ID NO: 55 can be used for the effective prevention or treatment of staphylococcus intramammary infection (IMI) caused by Staphylococcus aureus in a mammal.
14 cl, 27 dwg, 6 tbl, 27 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MUTANT IMMUNOGLOBULIN-BINDING POLYPEPTIDES | 2015 |
|
RU2712882C2 |
| RECOMBINANT MODIFIED FIBROBLAST GROWTH FACTORS AND THEIR THERAPEUTIC USE | 2018 |
|
RU2811435C2 |
| CD131-BINDING PROTEINS AND THEIR APPLICATIONS | 2016 |
|
RU2773927C2 |
| MONOCLONAL BINDING AGENTS, THEIR DRUG CONJUGATES AND THEIR APPLICATIONS | 2017 |
|
RU2744914C2 |
| ANTI-C10orf54 ANTIBODIES AND APPLICATIONS THEREOF | 2015 |
|
RU2819627C1 |
| IL-17A-BINDING POLYPEPTIDES | 2016 |
|
RU2749712C2 |
| ANTIBODIES DIRECTED AGAINST THE INTERLEUKIN 36 (IL-36R) RECEPTOR | 2016 |
|
RU2745898C2 |
| POLYPEPTIDES RECRUITING T-CELLS, CAPABLE OF BINDING CD123 AND ALPHA/BETA TCR | 2017 |
|
RU2775063C2 |
| CD123-SPECIFIC CHIMERIC ANTIGENIC RECEPTORS FOR CANCER IMMUNOTHERAPY | 2015 |
|
RU2727290C2 |
| ADAM9-BINDING MOLECULES AND THEIR APPLICATION METHODS | 2017 |
|
RU2783619C2 |
